Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorr

Showing results (831-840 of 1,229) with videos related to

Pageof 123
Sort By:
The Journal of Antimicrobial Chemotherapy|March 8, 2005
Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptideMary Beth Dorr, Daniela Jabes, Marco Cavaleri, et al.
Brain : a Journal of Neurology|February 18, 2015
Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's diseaseAaron Y Lai, Adrienne Dorr, Lynsie A M Thomason, et al.
Frontiers in Digital Health|November 6, 2025
Adapting data science competencies by role and purpose: Voice AIDavid A Dorr, Andrea Krussel, Rachel Hauck, et al.
Journal of Virology|December 22, 2006
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entryMike Westby, Caroline Smith-Burchnell, Julie Mori, et al.
Frontiers in Psychiatry|September 26, 2022
Bipolar disorders and retinal electrophysiological markers (BiMAR): Study protocol for a comparison of electroretinogram measurements between subjects with bipolar disorder and a healthy control groupGrégory Gross, Katelyne Tursini, Eliane Albuisson, et al.
Anti-Cancer Drugs|February 1, 1991
In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugsD S Alberts, R T Dorr, T P Wunz, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 6, 2003
Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patientsJacob P Lalezari, Indravadan H Patel, Xiaoping Zhang, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 21, 2021
Multimorbidity Accumulation Among Middle-Aged Americans: Differences by Race/Ethnicity and Body Mass IndexAnda Botoseneanu, Sheila Markwardt, Corey L Nagel, et al.
Journal of the American Geriatrics Society|May 12, 2006
Use of health-related, quality-of-life metrics to predict mortality and hospitalizations in community-dwelling seniorsDavid A Dorr, Spencer S Jones, Laurie Burns, et al.
Journal of General Internal Medicine|April 14, 2026
Deliberations on Government Spending Priorities: Listen to the PeopleSusan Dorr Goold, Zachary Rowe, Lydia Perry, et al.
Pageof 123

Showing results (831-840 of 1,229) with videos related to

Sort By:
Pageof 123
The Journal of Antimicrobial Chemotherapy|March 8, 2005
Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptideMary Beth Dorr, Daniela Jabes, Marco Cavaleri, et al.
Brain : a Journal of Neurology|February 18, 2015
Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's diseaseAaron Y Lai, Adrienne Dorr, Lynsie A M Thomason, et al.
Frontiers in Digital Health|November 6, 2025
Adapting data science competencies by role and purpose: Voice AIDavid A Dorr, Andrea Krussel, Rachel Hauck, et al.
Journal of Virology|December 22, 2006
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entryMike Westby, Caroline Smith-Burchnell, Julie Mori, et al.
Frontiers in Psychiatry|September 26, 2022
Bipolar disorders and retinal electrophysiological markers (BiMAR): Study protocol for a comparison of electroretinogram measurements between subjects with bipolar disorder and a healthy control groupGrégory Gross, Katelyne Tursini, Eliane Albuisson, et al.
Anti-Cancer Drugs|February 1, 1991
In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugsD S Alberts, R T Dorr, T P Wunz, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 6, 2003
Influence of subcutaneous injection site on the steady-state pharmacokinetics of enfuvirtide (T-20) in HIV-1-infected patientsJacob P Lalezari, Indravadan H Patel, Xiaoping Zhang, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 21, 2021
Multimorbidity Accumulation Among Middle-Aged Americans: Differences by Race/Ethnicity and Body Mass IndexAnda Botoseneanu, Sheila Markwardt, Corey L Nagel, et al.
Journal of the American Geriatrics Society|May 12, 2006
Use of health-related, quality-of-life metrics to predict mortality and hospitalizations in community-dwelling seniorsDavid A Dorr, Spencer S Jones, Laurie Burns, et al.
Journal of General Internal Medicine|April 14, 2026
Deliberations on Government Spending Priorities: Listen to the PeopleSusan Dorr Goold, Zachary Rowe, Lydia Perry, et al.
Pageof 123